Cancer drug sabizabulin may reduce risk of death from COVID-19
An experimental drug used to fight cancer may reduce the risk of death for COVID-19 patients by roughly 55%, a new study suggests.
News, articles, comments, with a minute-by-minute update, now on Today24.pro
Today24.pro — latest news 24/7. You can add your news instantly now — here